BioGaia AB (publ)

DB:BGLA Stock Report

Market Cap: €970.2m

BioGaia Past Earnings Performance

Past criteria checks 3/6

BioGaia has been growing earnings at an average annual rate of 19.4%, while the Biotechs industry saw earnings growing at 7.7% annually. Revenues have been growing at an average rate of 14.7% per year. BioGaia's return on equity is 20.8%, and it has net margins of 24.8%.

Key information

19.4%

Earnings growth rate

16.1%

EPS growth rate

Biotechs Industry Growth-14.6%
Revenue growth rate14.7%
Return on equity20.8%
Net Margin24.8%
Next Earnings Update12 Feb 2025

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How BioGaia makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

DB:BGLA Revenue, expenses and earnings (SEK Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 241,356337438101
30 Jun 241,369402430101
31 Mar 241,300371415113
31 Dec 231,297365403107
30 Sep 231,273437397110
30 Jun 231,213415385111
31 Mar 231,186413375101
31 Dec 221,104374361107
30 Sep 221,036273341106
30 Jun 22952246302103
31 Mar 22867222262103
31 Dec 21785196231105
30 Sep 21767196206105
30 Jun 21725164198105
31 Mar 21766188197104
31 Dec 20747180198105
30 Sep 2076719420399
30 Jun 20802211210105
31 Mar 20780193213106
31 Dec 19768187209105
30 Sep 19770192200111
30 Jun 19778205195110
31 Mar 19756207192107
31 Dec 18742215181100
30 Sep 1870220617394
30 Jun 1867519716686
31 Mar 1863118115378
31 Dec 1761518114976
30 Sep 1758417914370
30 Jun 1756217213969
31 Mar 1754216313267
31 Dec 1653516012964
30 Sep 1650013811857
30 Jun 1648012911453
31 Mar 1647813011152
31 Dec 1548313811253
30 Sep 1550013011560
30 Jun 1547411911459
31 Mar 154329711558
31 Dec 1448214710754
30 Sep 1445114610246
30 Jun 144331459843
31 Mar 144261429342
31 Dec 13316629441

Quality Earnings: BGLA has high quality earnings.

Growing Profit Margin: BGLA's current net profit margins (24.8%) are lower than last year (34.4%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: BGLA's earnings have grown by 19.4% per year over the past 5 years.

Accelerating Growth: BGLA's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: BGLA had negative earnings growth (-23%) over the past year, making it difficult to compare to the Biotechs industry average (-18.2%).

Return on Equity

High ROE: BGLA's Return on Equity (20.8%) is considered high.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 16:05
End of Day Share Price 2024/12/23 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

BioGaia AB (publ) is covered by 4 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Christopher UhdeABG Sundal Collier Sponsored
Kristofer Liljeberg-SvenssonCarnegie Investment Bank AB
Mattias HäggblomDanske Bank